9 research outputs found

    Knowledge and opinions of French dental students related to caries risk assessment and dental sealants (preventive and therapeutic)

    No full text
    Objectives - A national questionnaire study was performed to document knowledge and opinions of French dental students (FDSs) about minimal intervention (MI) in dentistry especially caries risk assessment (CRA) and dental sealants (DSs). Materials and methods - A questionnaire was administered to the fifth-year dental FDSs (n = 1370) from the 16 French dental schools. Descriptive and statistical analyses were performed. Results - The response rate was 84.5%. A large majority of respondents (87.8%) linked MI with minimally invasive dentistry and 77.4% considered MI as a concept based on prevention. About 80% stated they use CRA in clinical practice, mostly without any specific form. If 80.4% of the respondents would base their treatment plans on CRA, only 55.1% would regularly plan preventive regimens according to individual risk level. However, while 96.6% declared they perform preventive DSs, only 44.3% considered therapeutic sealants as a routine treatment. Although 75.1% of FDSs stated that they had sufficient learning and training related to CRA, 55.9% thought that they need further education about preventive and therapeutic DSs. Conclusion - Although FDSs seem to be aware of the importance of CRA and preventive strategies, this study shows the need to harmonize the teaching in cariology according to the latest European recommendations. Clinical relevance - A national questionnaire study showed variability towards knowledge and opinions of FDSs related to MI in cariology. This may impact care provisions in their future professional life showing the urgent need to harmonize the teaching of MI in cariology in France

    Cartographier les ressources pour gérer les priorités

    No full text
    International audienceComment, depuis plusieurs dĂ©cennies, la recherche scientifique contribue-t-elle au dĂ©veloppement des pays du Sud ? À travers plus de 100 succĂšs emblĂ©matiques de la recherche en partenariat, cet ouvrage nous plonge au coeur des grandes questions de dĂ©veloppement : oeuvrer pour des sociĂ©tĂ©s plus justes, lutter contre les maladies, faire face aux risques naturels, mettre en place une agriculture durable garantissant la sĂ©curitĂ© alimentaire, prĂ©server la biodiversitĂ©, partager les savoirs... Il montre ainsi comment la recherche contribue Ă  l'amĂ©lioration des conditions de vie et Ă  la prĂ©servation de l'environnement dans les pays en dĂ©veloppement, en soulignant le rĂŽle de la science pour rĂ©pondre aux dĂ©fis du monde actuel et Ă  venir. ComposĂ© de textes courts, didactiques et richement illustrĂ©s, il s'adresse Ă  tous les publics

    Cartographier les ressources pour gérer les priorités

    No full text
    International audienceComment, depuis plusieurs dĂ©cennies, la recherche scientifique contribue-t-elle au dĂ©veloppement des pays du Sud ? À travers plus de 100 succĂšs emblĂ©matiques de la recherche en partenariat, cet ouvrage nous plonge au coeur des grandes questions de dĂ©veloppement : oeuvrer pour des sociĂ©tĂ©s plus justes, lutter contre les maladies, faire face aux risques naturels, mettre en place une agriculture durable garantissant la sĂ©curitĂ© alimentaire, prĂ©server la biodiversitĂ©, partager les savoirs... Il montre ainsi comment la recherche contribue Ă  l'amĂ©lioration des conditions de vie et Ă  la prĂ©servation de l'environnement dans les pays en dĂ©veloppement, en soulignant le rĂŽle de la science pour rĂ©pondre aux dĂ©fis du monde actuel et Ă  venir. ComposĂ© de textes courts, didactiques et richement illustrĂ©s, il s'adresse Ă  tous les publics

    Science et développement durable : 75 ans de recherche au Sud

    No full text
    International audienceComment, depuis plusieurs dĂ©cennies, la recherche scientifique contribue-t-elle au dĂ©veloppement des pays du Sud ? À travers plus de 100 succĂšs emblĂ©matiques de la recherche en partenariat, cet ouvrage nous plonge au coeur des grandes questions de dĂ©veloppement : oeuvrer pour des sociĂ©tĂ©s plus justes, lutter contre les maladies, faire face aux risques naturels, mettre en place une agriculture durable garantissant la sĂ©curitĂ© alimentaire, prĂ©server la biodiversitĂ©, partager les savoirs... Il montre ainsi comment la recherche contribue Ă  l'amĂ©lioration des conditions de vie et Ă  la prĂ©servation de l'environnement dans les pays en dĂ©veloppement, en soulignant le rĂŽle de la science pour rĂ©pondre aux dĂ©fis du monde actuel et Ă  venir. ComposĂ© de textes courts, didactiques et richement illustrĂ©s, il s'adresse Ă  tous les publics

    Amantadine use in the French prospective NS-Park cohort

    No full text
    International audienceObjective: To assess amantadine use and associated factors in the patients with Parkinson's disease (PD).Background: Immediate-release amantadine is approved for the treatment of PD and is largely used in clinical practice to treat "levodopa-induced dyskinesia (LIDs). Its use varies according to countries and PD stages. The prospective NS-Park cohort collects features of PD patients followed by 26 French PD Expert Centres.Methods: Variables used for the analyses included demographics, motor and non-motor PD symptoms and motor complications [motor fluctuations (MFs), LIDs)], antiparkinsonian pharmacological classes and levodopa equivalent daily dose (LEDD). We evaluated: (i) prevalence of amantadine use and compared clinical features of amantadine users vs. non-users (cross-sectional analysis); (ii) factors associated with amantadine initiation (longitudinal analysis); (iii) amantadine effect on LIDs, MFs, apathy, impulse control disorders and freezing of gait (Fog) (longitudinal analysis).Results: Amantadine use prevalence was 12.6% (1,585/12,542, median dose = 200 mg). Amantadine users were significantly younger, with longer and more severe PD symptoms, greater LEDD and more frequent use of device-aided/surgical treatment. Factors independently associated with amantadine initiation were younger age, longer PD duration, more frequent LIDs, MFs and FoG, higher LEDD and better cognitive function. 9 of the 658 patients on amantadine had stopped it at the following visit, after 12-18 months (1.3%). New users of amantadine presented a higher improvement in LIDs and MF compared to amantadine never users.Conclusions: About 12% of PD patients within the French NS-Park cohort used amantadine, mostly those with younger age and more severe PD. Amantadine initiation was associated with a subsequent reduction in LIDs and MFs
    corecore